By: David Hamel, Fellow Scientist Cato Research Canada The FDA approval of Abilify MyCite (aripiprazole tablets with sensor; by Otsuka) on 13 November 2017 for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I … Continue reading
The post Toward Compliance 2.0 : When your Pill is Connected to your Smartphone appeared first on Ask Cato Research.